Main description:

Advances in Cancer Research, Volume 138, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine.

Contents:

1. Leveraging Epigenetics to Enhance the Cellular Response to Chemotherapies and Improve Tumor Immunogenicity Liliya Tyutyunyk-Massey, Syed Haqqani, Reshma Mandava, Kirubel Kentiba, Mallika Dammalapati, Nga Dao, Joshua Haueis, David Gewirtz and Joseph W. Landry 2. VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation Diana Fang and Eduardo N. Maldonado 3. Acquired Resistance to Drugs Targeting Tyrosine Kinases Steven A. Rosenzweig 4. Extracellular Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes Scott T. Eblen 5. Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases Mitchell E. Menezes, Praveen Bhoopathi, Anjan K. Pradhan, Luni Emdad, Swadesh K. Das, Chunqing Guo, Xiang-Yang Wang, Devanand Sarkar and Paul B. Fisher 6. Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics Jesse J. McClure, Xiaoyang Li and C. James Chou 7. Prospects of Gene Therapy to Treat Melanoma Mitchell E. Menezes, Sarmistha Talukdar, Stephen L. Wechman, Swadesh K. Das, Luni Emdad, Devanand Sarkar and Paul B. Fisher